Evaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBC
NCT02531425
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
ER-Negative PR-Negative HER2-Negative Breast Cancer
Interventions
BIOLOGICAL:
IT-pIL12-EP
Sponsor
OncoSec Medical Incorporated